Judge Christopher Lopez ruled that the company's attempt to use bankruptcy, filed under different names like Red River, was ...
The CNS market’s decade-long stagnation was driven by the high cost, complexity, and risk of drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback